81 related articles for article (PubMed ID: 3551961)
1. Proteoglycan degradation by a chondrocyte metalloprotease. Effects of synthetic protease inhibitors.
Caputo CB; Wolanin DJ; Roberts RA; Sygowski LA; Patton SP; Caccese RG; Shaw A; DiPasquale G
Biochem Pharmacol; 1987 Apr; 36(7):995-1002. PubMed ID: 3551961
[TBL] [Abstract][Full Text] [Related]
2. Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro.
Caputo CB; Sygowski LA; Wolanin DJ; Patton SP; Caccese RG; Shaw A; Roberts RA; DiPasquale G
J Pharmacol Exp Ther; 1987 Feb; 240(2):460-5. PubMed ID: 3543299
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors decrease rabbit cartilage degradation after meniscectomy.
Caputo CB; Sygowski LA; Patton SP; Wolanin DJ; Shaw A; Roberts RA; DiPasquale G
J Orthop Res; 1988; 6(1):103-8. PubMed ID: 3334729
[TBL] [Abstract][Full Text] [Related]
5. Degradation of rat chondrosarcoma proteoglycans by a neutral metalloprotease from rabbit chondrocytes.
Caputo CB; Sygowski LA; Patton SP; Piehl RF; Caccese RG; Dipasquale G
Connect Tissue Res; 1988; 18(3):191-203. PubMed ID: 2975581
[TBL] [Abstract][Full Text] [Related]
6. Two latent metalloproteases of human articular cartilage that digest proteoglycan.
Woessner JF; Selzer MG
J Biol Chem; 1984 Mar; 259(6):3633-8. PubMed ID: 6368548
[TBL] [Abstract][Full Text] [Related]
7. Passive loss of proteoglycan from articular cartilage explants.
Bolis S; Handley CJ; Comper WD
Biochim Biophys Acta; 1989 Dec; 993(2-3):157-67. PubMed ID: 2512986
[TBL] [Abstract][Full Text] [Related]
8. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
Steinmeyer J; Daufeldt S; Kalbhen DA
Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
Ganu V; Melton R; Wang W; Roberts D
Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
[No Abstract] [Full Text] [Related]
10. Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation.
Chandrasekhar S; Harvey AK
Biochem Biophys Res Commun; 1988 Dec; 157(3):1352-9. PubMed ID: 3144973
[TBL] [Abstract][Full Text] [Related]
11. Neutral proteinases from articular chondrocytes in culture. 2. Metal-dependent latent neutral proteoglycanase, and inhibitory activity.
Sapolsky AI; Malemud CJ; Norby DP; Moskowitz RW; Matsuta K; Howell DS
Biochim Biophys Acta; 1981 Mar; 658(1):138-47. PubMed ID: 6783102
[TBL] [Abstract][Full Text] [Related]
12. Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage.
Sabatini M; Rolland G; Léonce S; Thomas M; Lesur C; Pérez V; de Nanteuil G; Bonnet J
Biochem Biophys Res Commun; 2000 Jan; 267(1):438-44. PubMed ID: 10623638
[TBL] [Abstract][Full Text] [Related]
13. Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage.
Kawabata K; Moore AR; Willoughby DA
Ann Rheum Dis; 1996 Apr; 55(4):248-52. PubMed ID: 8733442
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and proteoglycan turnover in rabbit articular cartilage.
Stefanovic-Racic M; Möllers MO; Miller LA; Evans CH
J Orthop Res; 1997 May; 15(3):442-9. PubMed ID: 9246092
[TBL] [Abstract][Full Text] [Related]
15. The proteoglycanase from human cartilage and cultured rabbit chondrocytes and its relation to osteoarthritis.
Sapolsky S; Malemud C; Sheff M
J Rheumatol; 1987 May; 14 Spec No():33-5. PubMed ID: 3305935
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
17. Articular cartilage breakdown in a lapine model of osteoarthritis. Action of glycosaminoglycan polysulfate ester (GAGPS) on proteoglycan degrading enzyme activity, hexuronate, and cell counts.
Howell DS; Carreno MR; Pelletier JP; Muniz OE
Clin Orthop Relat Res; 1986 Dec; (213):69-76. PubMed ID: 3536251
[TBL] [Abstract][Full Text] [Related]
18. Modulation by transforming growth factor-beta 1 and interleukin-1 beta of proteoglycan release and chondrodisaccharide composition in porcine articular cartilage.
Zanni M; Tamburro A; Santone I; Rotilio D
Semin Thromb Hemost; 1994; 20(2):159-67. PubMed ID: 7997887
[TBL] [Abstract][Full Text] [Related]
19. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "Aggrecanase" activity.
Vankemmelbeke MN; Ilic MZ; Handley CJ; Knight CG; Buttle DJ
Biochem Biophys Res Commun; 1999 Feb; 255(3):686-91. PubMed ID: 10049771
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer.
Parvathy S; Oppong SY; Karran EH; Buckle DR; Turner AJ; Hooper NM
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):37-43. PubMed ID: 9355732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
